longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CLEARSIDE BIOMEDICAL INC

CLSDQ

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Q3 FY2025 Earnings

Financial report interval: 2025.06.30 - 2025.09.30

Overview: CLEARSIDE BIOMEDICAL INC(CLSDQ) the Revenue is 201 K (-80.64%);the EBIT is -7.04 M (-18.64%);the EPS is -1.14 (+26.04%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B80.64%
----
----
EBIT
-0.01B18.64%
----
----
EPS
-1.14126.04%
----
----

Revenue

ActualEstimateUnit: USD
qf

EBIT

ActualEstimateUnit: USD
qf

Net income

ActualEstimateUnit: USD
qf

EPS

ActualEstimateUnit: USD
qf